|
Demographics of the breast cancer population |
|
| Variable |
Number |
|
|
|
| Age, years (N = 23) |
|
| <45 |
3 |
| 45–55 |
8 |
| >55 |
12 |
| Menopausal status (N = 23) |
|
| Pre-/peri-menopausal |
16 |
| Post-menopausal |
7 |
| Tumor size (cm) (N = 23) |
|
| <2 |
12 |
| ≥2 |
11 |
| Nodal status (N = 22) |
|
| Negative |
11 |
| Positive |
11 (2 micrometasis) |
| Unknown |
1 |
| Tumor grade (SBR) (N = 20) |
|
| I |
9 |
| II |
9 |
| III |
2 |
| Histology (N = 20) |
|
| Ductal |
16 |
| Lobular |
1 |
| Other |
3 |
| ER status (N = 22) |
|
| Positive |
6 |
| Negative |
16 |
| Unknown |
1 |
| PR status (N = 22) |
|
| Positive |
8 |
| Negative |
14 |
| Unknown |
1 |
| HER-2 status (N = 21) |
|
| Positive |
20 |
| Negative |
1 |
| Unknown |
2 |
|
N = the number of specimens available for evaluation. ER, estrogen receptor; PR, progesterone receptor; SBR, Scarff, Blum, and Richardson. | |
Perkins et al. Breast Cancer Research 2006 8:R70 doi:10.1186/bcr1627 |
|